Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study

BACKGROUND: Concomitant seasonal influenza vaccination with a COVID-19 vaccine booster could help to minimise potential disruption to the seasonal influenza vaccination campaign and maximise protection against both diseases among individuals at risk of severe disease and hospitalisation. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Izikson, Ruvim, Brune, Daniel, Bolduc, Jean-Sébastien, Bourron, Pierre, Fournier, Marion, Moore, Tamala Mallett, Pandey, Aseem, Perez, Lucia, Sater, Nessryne, Shrestha, Anju, Wague, Sophie, Samson, Sandrine I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803382/
https://www.ncbi.nlm.nih.gov/pubmed/35114141
http://dx.doi.org/10.1016/S2213-2600(21)00557-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803382/
https://www.ncbi.nlm.nih.gov/pubmed/35114141
http://dx.doi.org/10.1016/S2213-2600(21)00557-9

Ejemplares similares